Digital Healthcare Market by Key Players, Regions, Type and Application, Forecast to 2025

 Market Overview

Market Research Future (MRFR) confirms that the Digital Healthcare Market 2020 can achieve a stunning growth rate of 26.30% from 2019 to 2025 (analysis period). The market is expected to be worth USD 3,28,887.8 Million by the end of the year 2025.

Growth Boosters and Deterrents

Telemedicine, blockchain electronic health records and artificial intelligence-backed devices are a few significant examples of digital healthcare, with these technologies reshaping the way health care professionals interact with each other and patients. These technologies have also transformed the way data is shared between healthcare providers, helping them to reach informed decisions as to how to proceed with the correct treatment plan to achieve successful outcomes. Innovation has been a key driver of the digital healthcare industry, with the increasing technological advancements leading to better streamlining of work, improved patient outcomes, lower human errors, and reduced costs.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7636 

The total number of smartphone owners crossed the five billion mark by the year 2019 and continues to mount at a rapid pace. Over four billion individuals worldwide, at any given point of time, use the Internet and are increasingly become aware of the benefits that digital healthcare has to offer. Doctors and other healthcare professionals are progressively adopting virtual-reality tools to either boost their medical skills or develop plans for a complicated surgery. Another significant trend in the digital healthcare market is the soaring popularity of the wearable technology. Seeing the escalating adoption of wearables in view of rising health consciousness among people, companies are proactively developing advanced devices that offer up-to-date tracking of high-risk persons to determine the possibility of any major illness or health issue.

Segment Analysis

The Global Digital Healthcare Market has been segmented by Technology, Application, Delivery Mode, Components, and End User.

The market, based on technology, has been bifurcated into digital health systems, telehealthcare, mhealth, and healthcare analytics. The digital health systems are further sub-segmented into EHR/EMR and e-prescribing systems. Telehealthcare is further segmented into activity monitoring, remote medication management, LTC monitoring, video consultation. mHealth is further segmented into wearables and mHealth apps. Wearables are furthermore segmented into glucose meters, neurological monitors, sleep apnea monitors, pulse oximeters, BP monitors, and others. mHealth apps is more segmented into fitness apps and medical apps.

Based on application, the digital healthcare market has been segregated into cardiology, diabetes, neurology, sleep apnea, oncology, and others.

Based on delivery mode, the digital healthcare market has been segregated into on-premise and cloud based.

Based on components, the digital healthcare market has been segregated into software, services, and

hardware.

The global digital healthcare market, based on end user, has been segmented into healthcare providers, healthcare payers, pharmaceutical companies, and others.

Regional Analysis

The Global Digital Healthcare Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is likely to hold the largest share of the global digital healthcare market during the assessment period. The high adoption rate of electronic health records (EHRs) and electronic medical records (EMRs), supportive government initiatives and rise in healthcare funding, and rising pressure to improve the quality of care and reduced healthcare costs likely drive the market growth in the American region.

The Europe market established substantial growth in the market due to the presence of major players such as Allscripts Healthcare, LLC (US), BioTelemetry, Inc. (US), Cerner Corporation (US), Cisco Systems, Inc (US), Koninklijke Philips NV (The Netherlands) and others.

Asia-Pacific is estimated to be the fastest-growing region in the global market due to the presence of rapidly developing economies such as China, India, and South Korea and a rise in research & development centers.

The digital healthcare market in the Middle East & Africa is expected to witness gradual growth owing to increasing government support toward the healthcare IT industry in the Middle East, and rapid technological advancements.

Key Players

MRFR recognizes the following companies as the Key Players in the Global Digital Healthcare Market— Allscripts Healthcare, LLC (US), BioTelemetry, Inc. (US), Cerner Corporation (US), Cisco Systems, Inc (US), Koninklijke Philips NV (The Netherlands), McKesson Corporation (US), General Electric Company (US), AT&T Inc.(US), Athenahealth Inc. (US), EClinicalWorks (US), iHealth Lab Inc. (US), Qualcomm Technologies, Inc.(US).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/digital-healthcare-market-7636 

Clinical Laboratory Test Market – Functional Survey 2022

 The Global Clinical Laboratory Test Market is expected to register 6.5% CAGR to reach USD 324508.8 Million by 2022.

Clinical laboratory testing has emerged as a rapidly growing segment in healthcare over the past few years. Clinical laboratory testing includes all routine check-ups and other pathology tests for the diagnosis of various diseases ranging from CBC and other routine blood tests to anatomical, pathological testing, molecular, immunological, drug testing, and other tests for disease diagnosis and treatment.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1649 

CBC and other routine blood tests are the most common type of tests that are used for screening certain disorders leading to an increase or decrease of cell counts. These tests help to diagnose a broad range of conditions from anemia and infections to cancer. Increasing prevalence of diseases and growing awareness and concerns regarding health issues all around the globe are the primary reasons for the growth of these routine check-ups and overall clinical laboratory testing market. On the other hand, the major factor restricting the growth of market is the strict government rules and regulations regarding laboratory testing. The global market has significant growth opportunities due to the various untapped therapeutic testing markets.

Market Dynamics of Clinical Laboratory test Market:

Drivers

The increasing prevalence of diseases and the growing population of the world is the critical driver of the market. The market is getting a boost from the growing screening programs initiated by the major governments. The inclusion of mandatory screening in the affordable healthcare act for newborns is expected to lead to a fast growth. Increasing awareness and growing bias towards evidence based medicines coupled with the growing volume of in-vitro diagnostic tests will also press the market growth.

The advent of biotech based tests such as DNA based tests are a large market opportunity as they result in greater selectivity and sensitivity. Growing trends towards self-diagnostic tests is expected to make a positive contribution to the markets. Panel based tests are the latest market trend due to their ease of use and single use systems. Automation is another trend driving the market as newer instruments have the capacity and capability to be linked and synced with another instruments. One such glaring example, is that of high pressure liquid chromatography and mass spectroscopy systems which save time and efforts.

Restraints

Stringent government rules and regulations and the high costs of the tests are the critical constraints on the market. The presence of spurious low cost products is hampering the market due to customer’s loss of faith. False results are other restraints as many older tests have low selectivity and detection limits to their targets.

Segments of Clinical Laboratory test Market:

Laboratory type - hospital based laboratories, central/independent laboratories, physician office laboratory (pol) and others. The market segmented by laboratory type is dominated by the hospital based laboratories.

Laboratory tests - Complete Blood Count (CBC) and other routine blood tests, anatomic pathology, molecular tests, immunology tests, drug testing and others. On the basis of laboratory tests, CBC and other routine blood tests are expected to hold the largest market share.

Regional Analysis of Clinical Laboratory test Market:

North America is the largest market share holder accounting for 44.6% of global clinical laboratory test market and is expected to generate a CAGR growth of 6.2%. U.S. is expected to be the prime market share holder of North America clinical laboratory testing market generating an anticipated CAGR  growth of 5.8%. Large number of laboratories and growing volume of clinical testing procedures are the prime reasons for the dominance of the U.S. Canada, is expected to be the fastest market in the North American region with an expected CAGR growth of 6.3%.

Europe is expected to be the second largest market for clinical laboratory test and is expected to generate a CAGR growth of 6.6%. Europe region is expected to be dominated by Germany owing to its highly developed medical device companies. Germany is expected to be followed by France and the U.K.

Asia-pacific region is expected to be the fastest growing market, with a growth rate of 6.5% to 7%  on account of growing awareness, strengthening government support and growing healthcare infrastructure.

Key Players for Clinical Laboratory test Market:                                        

Laboratory Corporation of America, LifeLabs Medical Laboratories, Sonic Healthcare, Aurora Diagnostics, Quest Diagnostics, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/clinical-laboratory-test-market-1649 

Hepatitis B Treatment Market Analysis and Value Forecast Snapshot by End-use Industry 2020-2027

 The global hepatitis B treatment market is expected to register an approximate CAGR of 5.3% during the forecast period, i.e., from 2018 to 2024.

Hepatitis is a viral infection caused by Hepatitis A, B or C virus. The infection results to cause liver infection or inflammation and many times leading to liver damage.

Hepatitis B virus spreads through coming in contact with infected blood, drinking contaminated water, and using infected needles or syringes.  The person suffering from Hepatitis B faces various symptoms such as poor appetite, weakness, jaundice, dark-colored urine, itching on skin, swelling on legs, weight loss, drowsiness and many more. According to the World Health Organization 2018 fact sheet, it was estimated that 257 million people across the world have lived with hepatitis B infection and also mentioned that around 887,000 number of people died from hepatitis B in 2015. Thus, the increasing prevalence of Hepatitis B across the world boosts market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7817 

However, the factors such as side effects associated with treatment and medications hinder the market growth.

Segmentation

The global hepatitis B treatment market is segmented on the basis of type, treatment, distribution channel, and region.
Based on type, the market is segmented into acute and chronic. On the basis of treatment, the global hepatitis B treatment market is segmented into immune modulator drugs, antiviral drugs, vaccine, and surgery  (liver transplant). The immune modulator drugs are further sub-segmented into pegylated interferon and interferon alpha. The antiviral drugs are sub-segmented into tenofovir disoproxil, entecavir, telbivudine, lamivudine, and others. By distribution channel, the market is segmented into hospital & retail pharmacies and online pharmacies.

Regional Analysis

The Americas dominates the global market for hepatitis B treatment. Factors such as the presence of a large number of healthcare companies, increasing geriatric population and high healthcare expenditure among the population within the Americas drives the market. The National Vaccine Information Center reported 3,370 cases of hepatitis B were reported in the US in 2015.

Following similar trends, Europe stood second in the global hepatitis B treatment market. The increased prevalence of viral diseases and growing healthcare expenditure in this region boost market growth. Also, the presence of developed economies, increasing healthcare facilities, and rising government funding for healthcare boost market growth. Asia Pacific was the fastest growing region for the global hepatitis B treatment market in 2017. This can be attributed due to the increasing incidences of HIV infection and rising demand for the treatment of viral infection among the population boosts market growth. 

On the other hand, the Middle East and Africa holds the least share in the global hepatitis B treatment market. The poor economies within the African region and lack of awareness about the treatment methods hinder the market growth.

Key Players

Some of the key players in the global hepatitis B treatment market are Accord Healthcare Inc., Apotex Corp., Arbutus Biopharma, Arrowhead Pharma, Aurobindo Pharma Limited, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline, Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Par Pharmaceutical, Inc., Teva Pharmaceuticals, Zydus Pharmaceuticals, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/sample_request/7817 

Medical Foods Market Growth, Demands, CAGR, Sales Volume, Opportunities, Types, Applications and Forecast up to 2027

 Market Scenario:

Medical foods are custom made liquid solutions used entirely, to treat consumers suffering from various diseases. Increasing chronic diseases among the growing population is driving the growth of the market. Moreover, nutritional deficiency is a common issue observed globally which will propel the growth of the global medical foods market.

Growing geriatric population is a major factor driving the growth of medical foods. Moreover, increasing awareness of nutritional benefits will surge the growth of medical foods. However, lack of knowledge among the consumers regarding medical foods is a major restraint to the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4915 

Market Definition:

Medical foods are principally formulated food products intended to be used under the supervision of medical and other appropriate health professionals. They work by supplying nutrition, not available in a normal diet, for the management of certain diseases such as Alzheimer’s, diabetic neuropathy, nutritional deficiency, depression, and others. They can be administered through oral or enteral route depending on the absorption capacity of the patient. Moreover, medical foods are made with Generally Recognized As Safe (GRAS) ingredients which include vitamins and minerals, proteins, omega-3, isoflavones, phytosterols, and others.

Downstream Analysis:

Medical foods market is segmented on the basis of nutritional ingredients such as vitamins and minerals, proteins, omega-3, isoflavones, phytosterols, and others. Among all, proteins segment is dominating the market. However, omega-3 is witnessed to be the fastest growing segment in nutritional ingredients used for medical foods since they help lower the risk of heart disease, depression, dementia, and arthritis.

Based on the form, medical foods market is segmented into pills, powder and others. Among all, powder form is dominating the market over the past years. However, pills segment is projected to be growing at the fastest rate which also includes tablets and capsules.

On the basis of ailment, medical foods market is segmented into Alzheimer’s diseases, diabetic neuropathy, nutritional deficiency, depression, and others. Among all, diabetic neuropathy is dominating the market as majority of the diabetic consumers suffer from some kind of neuropathy. However, nutritional deficiency segment is witnessed to be the fastest growing segment over the forecast period based on lack of nutrition level in patients suffering from any of the diseases.

Competitive Analysis:

The major players in the Medical Foods Market,

• Danone (France)
• Nestlé (Switzerland)
• Abbott (U.S.)
• Mead Johnson & Company, LLC (U.S.)
• Primus Pharmaceuticals Inc. (U.S.)
• Targeted Medical Pharma Inc. (U.S.)
• Fresenius Kabi AG (Germany)

Regional Analysis:

The global medical foods market is segmented into North America, Europe, Asia Pacific and rest of the world (RoW). North America is dominating the global market followed by Europe. Increasing awareness of medical foods in the U.S. and growing problem of Alzheimer’s diseases is driving the market for medical foods in this region.

Asia Pacific is projected to be the fastest growing region in which the major contributor is China. Continuous innovation and improved education towards medical foods will positively impact the market for rest of the world.

Market Segmentation:

Medical foods market is segmented on the basis of nutritional ingredients, form, ailment and the region.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-foods-market-4915 

Eyelashes Enhancing Agents Market – Comparative Analysis by 2027

 Market Scenario

Eyelash enhancing serum is a unique formula with lash enhancement, conditioning, moisturizing, and strengthening ingredients that collaboratively works to support and improve the overall appearance of eyelashes. A plenty of temporary lash-lengthening options are available in the market such as mascara and false eyelashes, which are available in the market, but there has been an influx of eyelash serums in stores that promise to strengthen and grow those tiny hairs. These eyelash enhancers have become increasingly popular due to their effective functional feature that turns drab, sparse, and brittle eyelashes into attractive and long eyelashes by the simple process of applying serums to the eyelash area. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4862

The global eyelashes enhancing agents market is growing moderately due to increasing prevalence of eye inflammations such as madarosis and blepharitis. Additionally, a shift in trend towards the natural eyelash enhancer agent, and continuous uptake of come higher medical dosages cause loss of eyelashes is likely to drive the market growth over the review period.

Breast cancer patients suffer from madarosis due to continuous session of intra-arterial chemotherapy. To cure this disease, a formulation of eyelash enhancer such as bimatoprost is used that maximizes eyelash and minimizes intraocular side effect. In case of blepharitis, there is loss of eyelashes occurs due to the presence of bacteria and oily flakes at the base of eyelashes. Blepharitis is a common disease, especially, among people who have oily skin, dandruff or dry eyes. According to International Journal of Development Research, blepharitis accounted for 700,000 patient visits in the US in 2014. Patients who have blepharitis take eyelash enhancer such as biotin as part of treatment. In some cases, blepharitis also causes loss of eyelashes (madarosis).

However, side-effects of eyelashes enhancer agents may affect the growth of the global eyelashes enhancing agents market, negatively.

The global eyelashes enhancing agents market is expected to grow at a CAGR of 5.83% during the forecast period 2017-2023. 

The global eyelashes enhancing agents market has been segmented on the basis of application, content, type, and lastly, region. The application-based segmentation of this market segments the market into repairing damaged eyelashes, nourishing eyelashes, and others. Based on content, the market has been segmented into bimatoprost, enhancer serum, herbal remedy, isopropyl cloprostenate, lash-building serum, skin care ingredients, and others.  The skin care ingredients have been sub-segmented into biotin, panthenol, polypeptides, and others. By type, the market has been segmented into curling, lengthening, volumizing, and others. Curling has been estimated to emerge as the fastest growing segment during the forecast period.

The regional segmentation of the global eyelashes enhancing agents market segments the market into the Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). The Americas segment holds the biggest share in the global market due to the huge development in the region’s cosmetic industry, presence of strong economic conditions, presence of many key market players, and focus by research institutions on research and development (R&D) in order to update the technology for new and advanced eyelashes enhancing agents. Due to advanced technology and the presence of many strong economies, North America is a bigger market than South America. The major country-specific markets in this region are the USA and Canada.

Europe is the second largest market due to the high density of population, changing lifestyle, growing cosmetics industry, increasing demand for eyelashes enhancing agents, and well-developed technology. Due to similar reasons as the Americas, Western Europe is a bigger market than Eastern Europe. In this region, the major country-specific markets are France, Germany, Italy, and the UK, followed by the remaining countries of Western as well as Eastern Europe.

The Asia Pacific region is the fastest growing regional market, and during the forecast period, it is expected to grow at a 6.26% CAGR. The main factor driving the market growth in this region is the presence of a number of developing nations like China and India in this region. In these countries, the growth of the cosmetics industry is aiding the market growth. Other factors contributing to market growth are the increasing prevalence of eye inflammations and the demand for various eyelashes enhancing agents. Other pivotal country-specific markets in this region are Japan and South Korea, followed by the remaining countries of Asia Pacific.

The MEA region holds the lowest market share due to less availability of medical facilities and lack of healthcare facilities. However, countries such as Kuwait and Qatar are focusing more on the healthcare and cosmetic industries. They are also developing medical facilities, which might create a stable market in this region during the forecast period.

Key Players:

The key players in the global eyelashes enhancing agents market include Allergan PLC (Republic of Ireland), Athena Cosmetics Inc. (USA), Beauty Essentials LLC (USA), Estee Lauder (USA), Grande Cosmetics LLC (USA), Rodan & Fields LLC (USA), and Skin Research Laboratories (USA).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/eyelashes-enhancing-agents-market-4862 

Diabetes Pen Market Growth, Demands, CAGR, Sales Volume, Opportunities, Types, Applications and Forecast up to 2027

 Insulin is a hormone produced by the pancreas.  A diabetes pen is used to inject insulin for the treatment of diabetes. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose. Diabetes is a major chronic disease across the globe. Changing lifestyle, high intake of carbohydrates and sugar, and obesity are major factors elevating the prevalence of the disease. Increasing prevalence of diabetes and obesity and growing demand for diabetes pen drive the market for diabetes pen.

The global diabetes pen market is expected to grow at a CAGR of approximately 8.45% during the forecast period 2017-2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/564 

Market Highlights
The global diabetes pens market is estimated to progress over the upcoming years due to increasing prevalence of diabetes and corresponding rise in the patients in need of regular insulin administration. Introduction of insulin pens and smart insulin pens have significantly contributed to rapid proliferation of diabetes injection pens market. Growing incidence of needle stick injury corresponding to the growing users of insulin injections is additionally driving patients to opt for diabetes injection pens.  
During forecast period 2017 to 2023, the global diabetes pen market is expected to reach USD 9.85 billion by 2023 at a CAGR of 8.45%
Taste the market data and market information presented through more than 52 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Diabetes Pen Market Research Report –Global Forecast till 2023.”

Global Diabetes Pen Market Players
Key players in diabetes pen market: AstraZeneca (U.K), Teruma Medical Corporation (Japan), Greinier Bio One International GmBH (U.S.), F. Hoffman La Roche AG (Switzerland), Becton, Dickinson and Company (U.S.), Bayer Cropscience Ltd. (Germany), and HTL STREFA SA (Poland)

Regional Analysis
Globally, diabetes pen market consists of four regions: North America, Europe, Asia Pacific. and Middle East & Africa. North America is expected to be the largest market for diabetes pen. Reimbursement for diabetes management and technological advancement in production of diabetes pens to administer accurate and safe dose drive this market.  Extensive research and development to enhance the quality of diabetes pens as well as to increase their reliability is also another reason for the growth of this market in North America. Large number of diabetes pen users have been found in European countries, especially in the U.K. leading to an increase in their demand.  Asia Pacific is expected to be fastest growing market for diabetes pen with India being the largest market due to growing expenditure in the healthcare to curb lifestyle disease and improved healthcare infrastructure. The Middle East & Africa, major drivers for rise in this market are initiative to control the elevated levels of diabetes and awareness regarding lifestyle diseases.

Segmentation:

The global diabetes pen market is segmented on the basis of product, which includes insulin pens and insulin pen needle. On the basis of usage, the market is segmented into includes reusable pens and disposable pens used of diabetes pen. And on the basis of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, online sales, and diabetes clinics.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/global-diabetes-pen-market-564 

Antihistamine Drugs Market Report 2020 with Key Players, Regions, Trends, Market Growth, SWOT Analysis and Forecast to 2027

 Antihistamines are drugs mainly used for treating allergies. They are also used to treat motion sickness, insomnia and anxiety. They work by acting against a chemical called histamine which leads to many allergic symptoms. Antihistamines may cause side effects such as dizziness, dry mouth, nervousness, irritability, blurry vision and decreased appetite.

The global antihistamine drugs market is expected to grow at a CAGR of 9.8% during the forecast period and is estimated to reach USD 280 million by 2027.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4266 

Major players in antihistamine drugs market

Some of the key players in the global market are Johnson & Johnson Consumer Inc. (U.S.), Sanofi (France), Bayer AG (Germany), Pfizer (U.S.), CVS pharmacy (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), and Prestige Brands Holdings, Inc. (U.S.)

Regional Analysis

The global antihistamine drugs market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominate the global antihistamine drugs market. It comprises of two regions namely North America and South America. North America in the largest market owing to development of new antihistamine drugs by major market players for the treatment of allergies.

In Europe, rising awareness about sedating and non-sedating antihistamine drugs and their side effects as well as precautionary awareness drives this market. Furthermore, increasing prevalence of allergy rhinitis is found in European nations which further propels the market growth.

Asia Pacific is the fastest growing and potential market for antihistamine drugs, whose growth is attributed to the rising awareness about allergic conditions and availability of medications for its treatment.

The Middle East & Africa is expected witness steady growth owing to the rising demand for drugs and healthcare resources in this region.

Segmentation

The global antihistamine drugs market is segmented on the basis of types which includes sedating and non-sedating antihistamines. Sedating antihistamines are further sub-segmented into brompheniramine, chlorpheniramine, diphenhydramine, doxylamine, carbinoxamine and others. Non-sedating antihistamines are further sub-segmented into fexofenadine, loratadine, loratadine odt, and others.

On the basis of route of administration, the market is segmented into oral route, parenteral route and rectal route. Parenteral route segmented is further sub-segmented into intramuscular, subcutaneous and intravenous route.

On the basis of indication, the market is segmented into allergy, urticaria, dermatitis, and others. And on the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/antihistamine-drugs-market-4266